Christopher Bunka - 26 Oct 2023 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Signature
/Chris Bunka/
Issuer symbol
LEXX
Transactions as of
26 Oct 2023
Net transactions value
$0
Form type
4
Filing time
30 Oct 2023, 12:30:47 UTC
Previous filing
18 Oct 2022
Next filing
10 May 2024

Key filing fact

Christopher Bunka filed Form 4 for Lexaria Bioscience Corp. (LEXX) on 30 Oct 2023.

Key facts

  • This page summarizes Christopher Bunka's Form 4 filing for Lexaria Bioscience Corp. (LEXX).
  • 1 reported transaction and 6 derivative rows are listed below.
  • Filing timestamp: 30 Oct 2023, 12:30.

Change

  • Previous filing in this sequence was filed on 18 Oct 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

LEXX holding

common shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
273,543
Date
26 Oct 2023
Ownership
Direct
LEXX holding

common shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
254,412
Date
26 Oct 2023
Ownership
Private Holding Company

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

LEXX transaction Derivative

Stock Options

Award

Transaction value
$0
Shares
+30,000
Change %
+30%
Price
$0.000000
Shares after
131,001
Date
26 Oct 2023
Ownership
Direct
Underlying class
Common Shares
Underlying amount
30,000
Exercise price
$1.15
LEXX holding Derivative

Warrants

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,667
Date
26 Oct 2023
Ownership
Private Holding Company
Underlying class
Common Shares
Underlying amount
6,667
Exercise price
$10.50
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
32,667
Date
26 Oct 2023
Ownership
Direct
Underlying class
Common Shares
Underlying amount
26,000
Exercise price
$3.00
Footnotes
F1
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
56,001
Date
26 Oct 2023
Ownership
Direct
Underlying class
Common Shares
Underlying amount
23,334
Exercise price
$3.00
Footnotes
F2
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
71,001
Date
26 Oct 2023
Ownership
Direct
Underlying class
Common Shares
Underlying amount
15,000
Exercise price
$3.00
Footnotes
F3
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
101,001
Date
26 Oct 2023
Ownership
Direct
Underlying class
Common Shares
Underlying amount
30,000
Exercise price
$2.91
An asterisk next to the price means the reported price is likely invalid.

Explanation of Responses:

Id Content
F1 Repriced from $5.83 pursuant to shareholder approval received on May 9, 2023
F2 Repriced from $7.08 pursuant to shareholder approval received on May 9, 2023
F3 Repriced from $6.23 pursuant to shareholder approval received May 9, 2023
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .